J&J's Janssen Says 3rd Circ. Should Reverse $1.6B FCA Win
By Jarek Rutz · October 30, 2025, 7:06 PM EDT
Johnson & Johnson's Janssen Products LP urged the Third Circuit to overturn a $1.6 billion False Claims Act judgment over two of its HIV drugs, arguing the district court allowed whistleblowers...
To view the full article, register now.